For instance, major changes in GM composition, together with quickened aging and neurodegenerative hallmarks such as tau phosphorylation, β-amyloid formation, and neuroinflammation, have been observed in patients affected by AD [52,53]. This evidence concerns the gene MAPT and Alzheimer disease.